𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PARP and other prospective targets for poisoning cancer cell metabolism

✍ Scribed by Michels, Judith; Obrist, Florine; Castedo, Maria; Vitale, Ilio; Kroemer, Guido

Book ID
126727104
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
600 KB
Volume
92
Category
Article
ISSN
0006-2952

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy of everolimus in second- and th
Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis11T.B. and B.M. received honoraria for advisory boards and lectures from Novartis and Pfizer. K.K. received honoraria for advisory boards and lectures from Novartis. Other authors have declared no conflict of interest. The RENIS registry is funded in part by pharmaceutical companies producing targeted agents for renal cancer (Pfizer, Bayer, GSK, Roche, and Novartis).
✍ Buchler, Tomas; Bortlicek, Zbynek; Poprach, Alexandr; Kubackova, Katerina; Kiss, πŸ“‚ Article πŸ“… 2014 πŸ› Elsevier Science 🌐 English βš– 327 KB